Tourmaline Bio
TRML
TRML
96 hedge funds and large institutions have $470M invested in Tourmaline Bio in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
39% more capital invested
Capital invested by funds: $338M → $470M (+$132M)
16.15% more ownership
Funds ownership: 64.01% → 80.15% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
96
Holding in Top 10
5
Calls
$10.8M
Puts
$3.98M
Top Buyers
| 1 | +$31M | |
| 2 | +$28.6M | |
| 3 | +$25.5M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$10.8M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$10.6M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$7.42M | |
| 3 | -$6.43M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.05M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.24M |